Recent studies have found that gain-of-function mutation of STING leads to vasculopathy [50, 51] and apoptosis-derived membrane vesicles in SLE serum to induce type I interferon production through activation of the cGAS–STING pathway [52]. Here, STING1 is linked to vascular disorder.